Current Clinical Studies
The MultiCare Pulmonary Specialists clinical research team is dedicated to the discovery of new medications through Phase II, III and IV clinical research. Our research trials are conducted on site with human subjects in order to test the safety, tolerability and efficacy of investigational drugs as well as to aid in the development of new technologies and/or devices. All studies are sponsored and closely monitored by pharmaceutical and biotech companies, and all studies are FDA and IRB approved.
Diagnosis: COPD
Study Number: 09-01
Age: 40-65 years of age
Smoking History: = 20 pack years (i.e. 1 pack per day for 20 years)
Sex: Males and Females
Visits: 12 visits over 2 years
Stipend: You will be compensated for your time and travel
In this research study, we are testing an investigational drug for COPD patients who have had an exacerbation within the last 12 months.
Diagnosis: Chronic Obstructive Pulmonary Disease (COPD)
Study Number: 11-02
Age: 40 years or older
Sex: Males and Females
Visits: 11 visits over approximately 1 year
Costs: As a qualified participant, you will receive study-related medical care at no cost to you and you may receive reimbursement for certain travel costs.
In this research study, we are testing an investigational inhaled drug for subjects with COPD with a smoking history of more than 10 pack years.
Diagnosis: SEVERE ASTHMA
Study Number: 11-07
Age: 18-65 years old
Sex: Males and Females
Visits: Approximately 13 visits over approximately 5 years
Stipend: You will be compensated for your time and travel
In this research study, we are testing an FDA approved device for the treatment of Severe Asthma. You will undergo three procedures (Bronchial Thermoplasty) and continue to be followed for approximately 5 years.
Diagnosis: Asthma
Study Number: 11-09
Age: At least 12 years of age or older
Sex: Males and Females
Visits: Approximately7 visits over 16 weeks
Stipend: You will be compensated for your time and travel.
In this research study, we are testing a new investigational method of delivery for Symbicort.
Diagnosis: COPD
Study Number: 11-10
Age: At least 40 years of age
Sex: Males and Females
Visits: 7 visits over approximately 6 months
Stipend: You will be compensated for your time and travel
In this research study, we are testing an investigational drug for subjects with COPD who have at least a 10 pack year smoking history.
Diagnosis: Asthma
Study Number: 11-13
Age: At least 12 years of age or older
Sex: Males and Females
Visits: Approximately 5 visits + 3 phone calls over 6 months
Stipend: You will be compensated for your time and travel.
In this research study, we are evaluating the risk of serious asthma-related events after treatment with Inhaled Corticosteroids (ICS) BUDESONIDE in combination with a long acting beta-agonist (FORMOTEROL) as compared to treatment with BUDESONIDE alone.